The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets pull back as investors prepare for Fed meeting

Tue, 17th Dec 2013 11:24

- US inflation in focus ahead of Fed meeting- German sentiment rises; UK inflation eases- S&P downgrades RSA, Fitch lowers outlook- Cable & Wireless Comms gains on bid speculationtechMARK 2,690.49 +0.16%FTSE 100 6,499.13 -0.35%FTSE 250 15,419.43 +0.23%Markets across Europe were trading in the red on Tuesday morning after a strong showing the day before as investors adopted a cautious approach ahead of the Federal Reserve meeting."Yesterday's rally led many to believe that tapering had either been fully priced in or that investors did not believe the Fed would act at this month's meeting. The response seen in US futures and European indices during the morning session would suggest otherwise," said Market Analyst Craig Erlam from Alpari.This FTSE 100 jumped by 1.3% on Monday, as bargain hunters stepped in to buy on the dips after four straight days of losses which saw the index hit its lowest level since mid-October."Today we're seeing more risk aversion from investors, which isn't overly surprising given that the FOMC will announce tomorrow whether it will scale back its asset purchases or not. Investors appear split on this at the moment, with some pointing to the significant improvement in the data and others warning about the low levels of inflation," Erlam said.As such, investors will be looking closely at November's US consumer price index (CPI) due out later on which is expected to show that inflation picked up to an annualised rate of 1.3% in November, up from 1% the previous month. The core figure, which excludes volatile things such as food and energy, is expected to be unchanged at 1.7%Investors have had plenty of economic data to digest today on this side of the Pond, including a German sentiment survey which smashed forecasts by rising to its highest level since April 2006. Meanwhile, the rate of UK CPI inflation unexpectedly fell to 2.1% last month, edging close to the Bank of England's 2% target.RSA gains despite downgrades; C&W up on bid rumoursRSA Insurance was making gains this morning but continues to trade well below levels seen last week after Friday's profit warning and resignation of its Chief Executive. Subsequently, S&P downgraded its credit rating on the stock on Monday to 'A-' with a 'Developing Outlook', having already downgraded last week, while Fitch cut its outlook to 'Rating Watch Negative'.Telecoms group Cable & Wireless Communications was continuing to rise on speculation that it could be a takeover target of US giant AT&T. The stock rose by 4% yesterday.Temporary power and temperature control group Aggreko was among the heaviest fallers, retreating after a stellar rise the day before as it said that full-year results would be slightly ahead of expectations.Barclays fell after calling for the US courts to block energy regulators from collecting $488m of fines for electricity trading market manipulation. Pharmaceuticals group GlaxoSmithKline declined early on after Deutsche Bank downgraded the stock to 'hold'.Consumer electricals group Dixons declined despite beating forecasts with its first underlying profit in six years during if first half. However, the company did warn that the second half would be tougher.AIM-listed iodine producer Iofina was a big mover this morning, plummeting by nearly a quarter after a profit warning. The company said that underlying earnings this year are likely to be similar to 2012 after expected 2013 shipments from its chemical division were delayed into 2014.FTSE 100 - RisersRSA Insurance Group (RSA) 91.30p +1.33%Sage Group (SGE) 379.40p +1.17%Aberdeen Asset Management (ADN) 458.20p +1.13%Rio Tinto (RIO) 3,251.00p +1.01%Sports Direct International (SPD) 709.00p +0.93%International Consolidated Airlines Group SA (CDI) (IAG) 385.40p +0.89%Persimmon (PSN) 1,154.00p +0.87%TUI Travel (TT.) 393.30p +0.85%United Utilities Group (UU.) 668.50p +0.83%Johnson Matthey (JMAT) 3,217.00p +0.66%FTSE 100 - FallersAdmiral Group (ADM) 1,229.00p -2.54%Petrofac Ltd. (PFC) 1,126.00p -2.34%Aggreko (AGK) 1,611.00p -2.07%Burberry Group (BRBY) 1,445.00p -1.70%Vedanta Resources (VED) 785.00p -1.51%BP (BP.) 466.30p -1.46%Fresnillo (FRES) 718.50p -1.37%Hargreaves Lansdown (HL.) 1,281.00p -1.31%CRH (CRH) 1,468.00p -1.28%Amec (AMEC) 1,046.00p -1.23%FTSE 250 - RisersPerform Group (PER) 250.00p +5.93%Fidessa Group (FDSA) 2,377.00p +3.89%Redrow (RDW) 297.20p +3.48%Synthomer (SYNT) 239.20p +3.28%IP Group (IPO) 169.00p +3.05%CSR (CSR) 614.50p +2.76%Cable & Wireless Communications (CWC) 50.25p +2.55%Inchcape (INCH) 592.00p +2.51%Savills (SVS) 646.00p +2.38%St. Modwen Properties (SMP) 368.50p +2.36%FTSE 250 - FallersAlent (ALNT) 337.20p -3.05%esure Group (ESUR) 239.90p -2.87%UBM (UBM) 632.00p -2.77%Dixons Retail (DXNS) 49.99p -2.55%Debenhams (DEB) 83.85p -2.33%AL Noor Hospitals Group (ANH) 901.50p -2.01%Ladbrokes (LAD) 167.20p -1.88%Informa (INF) 525.50p -1.78%Kenmare Resources (KMR) 19.66p -1.70%Xaar (XAR) 1,096.00p -1.62%BC
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.